Business

May 8, 2014

Charlotte-based drug company to be acquired in $658M deal

Charlotte-based drug development company Chelsea Therapeutics has agreed to be acquired by Danish pharmaceutical company Lundbeck for up to $658million, following the FDA’s approval earlier this year of Chelsea’s medication for treating dizziness and fainting in adults.

Related content

Comments

Editor's Choice Videos